Dihydroergotamine Mesylate Spray, Metered
Product Images NDC 70069-880

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dihydroergotamine Mesylate (NDC 70069-880). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (8d88a6e3 0b91 4414 Acce 4de8bb371ac1 01)

Dihydroergotamine mesylate is a chemical compound with a molecular weight of 679.80 g/mol. It likely has pharmaceutical or research applications.*

FDA Label Image

Image (8d88a6e3 0b91 4414 Acce 4de8bb371ac1 02)

This is a description of figure 1 showing the estimated probability of a patient responding during the four hours following a single 2 mg dose of Dihydroergotamine Mesylate Nasal Spray. The graph represents the probability of response to the study medication over time for Studies 1 and 2, with a total sample size of 208 patients in the Dihydroergotamine Mesylate group and 200 patients in the Placebo group. The x-axis represents the time elapsed from the first dose in hours, while the y-axis shows the estimated probability of response to the medication.*

FDA Label Image

Image (8d88a6e3 0b91 4414 Acce 4de8bb371ac1 03)

FDA Label Image

Image (8d88a6e3 0b91 4414 Acce 4de8bb371ac1 04)

Estimated Probability of Patients Using Additional Treatments for Migraine Over the 24 Hours Following either Dihydroergotamine Mesylate Nasal Spray 2 mg (or placebo) Hours After First Spray.*

FDA Label Image

Image (8d88a6e3 0b91 4414 Acce 4de8bb371ac1 05)

This text appears to be a medication label for dihydroergotamine. The medication is meant for nasal administration only and contains 4 mg of mesylate per 1 mL. It is specified that it is not for injection. The product is manufactured for Somerset Therapeutics, LLC, located in Somerset, NJ, and it is stated that it is made in Italy. The NDC (National Drug Code) for this product is 70069-830-01.*

FDA Label Image

Image (8d88a6e3 0b91 4414 Acce 4de8bb371ac1 06)

FDA Label Image

Image (8d88a6e3 0b91 4414 Acce 4de8bb371ac1 07)

This text contains information on a nasal spray product containing Dihydroergotamine Mesylate. The product is manufactured for Somerset Therapeutics, LLC and contains components such as caffeine, dextrose, carbon dioxide, and purified water. The kit includes vials and nasal sprayers for administering the medication. It is emphasized that the nasal spray is for nasal use only, not for injection, and should be discarded after use or after 8 hours. Further details can be found in the enclosed package insert and administration instructions. It is advised to store the product below 25°C and not to refrigerate or freeze it.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.